Serum Transthyretin Before and After Starting Tafamidis as Outcome Predictors in ATTR Cardiomyopathy - PubMed
3 days ago
- #outcome
- #tafamidis
- #cardiac amyloidosis
- Study focuses on serum transthyretin levels before and after tafamidis treatment as predictors of outcomes in ATTR cardiomyopathy.
- Supported by a grant from Fondazione Pisa (Grant Number 313/22).
- Authors report no conflicts of interest related to the study.